# Hemothorax after fetal pleural effusion-thoracoamniotic shunting procedure due to transient myeloproliferative disorder

**Authors:** Yuriko Iwahata, Hideyuki Iwahata, Junichi Hasegawa, Chika Homma, Yoko Nishimura, Haruhiro Kondo, Nao Suzuki

PMC · DOI: 10.1515/crpm-2021-0032 · Case Reports in Perinatal Medicine · 2022-06-11

## TL;DR

A fetus with fluid buildup underwent a procedure that led to hemothorax, later linked to a rare blood disorder and genetic condition.

## Contribution

Highlights a rare complication of thoracoamniotic shunting in fetuses with transient myeloproliferative disorder.

## Key findings

- Fetal hemothorax occurred after two thoracoamniotic shunting procedures.
- The infant was diagnosed with trisomy 21 and transient myeloproliferative disorder.
- Technical care is essential during thoracoamniotic shunting despite not all cases showing hemothorax.

## Abstract

To present a case of fetal hemothorax after two times of thoracoamniotic shunting (TAS) performed to pleural effusion with hydrops fetalis, resulting in non-reassuring fetal status due to hemothorax.

This is a case of bilateral pleural effusion with hydrops fetalis and polyhydramnios at 32 weeks gestation, in which unilateral fetal TAS was performed twice, resulting in non-reassuring fetal status due to hemothorax. After delivery, the infant was diagnosed with trisomy 21 and transient myeloproliferative disorder (TMD) with disseminated intravascular coagulation and congenital systemic lymphangiopathy.

In conclusion, since TAM case do not always show hemothrax, TAM is not inhibited but technical carefulness should be necessary.

## Linked entities

- **Diseases:** hydrops fetalis (MONDO:0015193), transient myeloproliferative disorder (MONDO:0008040), disseminated intravascular coagulation (MONDO:0001243)

## Full-text entities

- **Diseases:** hydrops fetalis (MESH:D015160), Hemothorax (MESH:D006491), pleural effusion (MESH:D010996), polyhydramnios (MESH:D006831), TMD (MESH:C563551), congenital systemic lymphangiopathy (MESH:D009421), disseminated intravascular coagulation (MESH:D004211), myeloproliferative disorder (MESH:D009196), trisomy 21 (MESH:D004314)
- **Chemicals:** TAM (MESH:D013629)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11800672/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11800672/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC11800672/full.md

---
Source: https://tomesphere.com/paper/PMC11800672